Phase II trial of palliative intra-arterial epirubicin/5FU therapy for patients with chemotherapy-refractory locally-advanced or metastatic breast cancer
Phase 2
Recruiting
- Conditions
- locally-advanced and metastatic breast cancer
- Registration Number
- JPRN-UMIN000013242
- Lead Sponsor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
a)History of non-breast malignancies within the 5 years prior to study entry b)Symptomatic breast metastasis c)Concurrent serious diseases that may interfere with planned treatment d) Stenosis of subclavian artery by contrast-enhanced CT e) bilateral breast cancer or multiple lesions within the region f) Pregnant or lactating women g) Patient unfeasible for ambulatory chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method local response rate
- Secondary Outcome Measures
Name Time Method